Option Care Health (NASDAQ:OPCH) Hits New 12-Month High – Still a Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $35.46 and last traded at $34.97, with a volume of 529 shares trading hands. The stock had previously closed at $34.58.

Analysts Set New Price Targets

Several analysts have issued reports on OPCH shares. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Barrington Research lifted their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Price Performance

The firm’s 50 day simple moving average is $32.11 and its two-hundred day simple moving average is $28.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.78 billion, a P/E ratio of 29.56, a P/E/G ratio of 2.30 and a beta of 1.33.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

Institutional investors have recently made changes to their positions in the stock. Murphy & Mullick Capital Management Corp bought a new stake in Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. increased its position in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after purchasing an additional 332 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.